Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities
- PMID: 22802368
- PMCID: PMC3029437
- DOI: 10.1136/bcr.05.2010.2993
Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities
Abstract
A 55-year-old Filipina with Grave's disease, diabetes, hypertension, bronchial asthma, Parkinson's disease and a history of adverse drug reaction to penicillin consulted due to high-grade fever and sore throat. Patient was diagnosed with aplastic anaemia secondary to methimazole and was treated with high-dose granulocyte colony stimulating factor, thrombopoietin and mesterolone. Antibiotics used included levofloxacin, clindamycin, amikacin and fluconazole. Due to bleeding and slow recovery of blood parameters, 30 units of platelets and 7 units of packed red blood cells were transfused during her 22-day admission. This case presents a life-threatening adverse drug reaction in a patient with co-morbid conditions that complicate recovery and limit one's therapeutic options.
Conflict of interest statement
Figures
References
-
- Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905–17 - PubMed
-
- Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 2004;14:459–62 - PubMed
-
- Young NS. Aplastic Anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. Sixteenth edition New York, NY: McGraw-Hill; 2005:617–26
-
- Thomas D, Moisidis A, Tsiakalos A, et al. antithyroid drug-induced aplastic anemia. Thyroid 2008;18:1043–8 - PubMed
-
- Yamamoto A, Katayama Y, Tomiyama K, et al. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis. Thyroid 2004;14:231–5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical